Abstract: The present disclosure relates to a vehicle rear seat including: a center seat; and side seats located on the left and right of the center seat, wherein, the center seat is capable of protruding by moving the center seat forward with respect to the side seats, and in the state in which the center seat protrudes forward, it is possible to increase an inter-passenger distance so that physical contact between the passenger of the center seat and the passenger of each of the side seats can be prevented as much as possible.

Abstract: An image sensor includes a plurality of unit pixels, each including: a substrate including first and second sides which are opposite to each other, a photoelectric conversion layer in the substrate, and a wiring structure on the first side of the substrate. The wiring structure may include: a first capacitor, a second capacitor spaced from the first capacitor, a plurality of edge vias arranged along edges of the unit pixel, and a plurality of central vias interposed between the first capacitor and the second capacitor.

Abstract: The present disclosure includes cationic carrier units comprising (i) a water soluble polymer, (ii) a positively charged carrier, and (iii) an adjuvant moiety, wherein when the cationic carrier unit is mixed with an anionic payload (e.g., an antisense oligonucleotide) that electrostatically interacts with the cationic carrier unit, the resulting composition self-organizes into a micelle encapsulating the anionic payload in its core. The cationic carrier units can also comprise a tissue specific targeting moiety, which would be displayed on the surface of the micelle. The disclosure also includes micelles comprising the cationic carrier units of the disclosure, methods of manufacture of cationic carrier units and micelles, pharmaceutical compositions comprising the micelles, and also methods of treating diseases or conditions comprising administering the micelles to a subject in need thereof.

Abstract: A menu providing apparatus comprise at least: a menu data collection unit which collects menu data through a network and stores the menu data in a menu database; a menu generation unit which generates menus by learning the menu data; a menu recommendation unit which transmits recommended menus to a user terminal and receives, from the user terminal, information about a selected menu and the number of meals; a menu modification unit which receives, from the user terminal, a modification command for the recommended menus, modifies the recommended menus according to the modification command, and transmits the same to the user terminal; and a food ingredient ordering unit which derives types of food ingredients according to the selected menu, calculates the required quantity for each type of food ingredient according to the number of meals, and transmits the same to a food ingredient supplier terminal.

Abstract: According to one example embodiment, an apparatus includes a kiosk device, a plurality of cameras, and a processor, which check an authenticity and an identification information about a specified user by checking the identification information about the user recognized in the image obtained by capturing the space, and then tracks the motion of the user for which the authenticity has been checked using a user tracking algorithm, generate exercise habit information about the user by using bio-signals and motion signals of the user, which are acquired from the time when an exercise using fitness equipment provided in the space starts to the time when the exercise ends, generate exercise method information to be recommended to the user by using the identification information about the user and the exercise habit information about the user, and provides the generated exercise method information to the user.

Abstract: The present disclosure includes the use of a miRNA inhibitor for treating a symptom or condition of Huntington’s disease. The miRNA inhibitor useful for the present disclosure can inhibit miR-485 expression and/or activity, which in turn can modulate the level of proteins or gene expression related to Huntington’s disease.

Abstract: The present disclosure relates to the use of miR-485-3p expression to identify a subject that is afflicted with a cognitive disorder. In some aspects, the methods disclosed herein further comprises administering a miR-485-3p inhibitor to the subject, wherein the miR-485-3p inhibitor is capable of treating the cognitive disorder.

Abstract: Provided are an apparatus and a method for controlling an interrupt rate for a processor based on processor utilization. Accordingly, it is possible to improve an I/O response latency and improve energy efficiency.

Abstract: The present disclosure includes the use of a miRNA inhibitor for treating amyotrophic lateral sclerosis (ALS) associated with a decreased level of SIRT1 protein or SIRT1 gene expression, PGC-1? protein and/or PGC-1? gene expression, CD36 protein and/or CD36 gene expression, NRG1 protein and/or NRG1 gene expression, STMN2 protein and/or STMN2 gene expression, and/or NRXN1 protein and/or NRXN1 gene expression.

Abstract: The present disclosure includes the use of a miRNA inhibitor for treating a disease or condition associated with a decreased level of SIRT1, PGC-1?, CD36, LRRK2, NRG1, STMN2, VLDLR, NRXN1, GRIA4, NXPH1, PSD-95, and/or synaptophysin protein or SIRT1, PGC-1?, CD36, LRRK2, NRG1, STMN2, VLDLR, NRXN1, GRIA4, NXPH1, PSD-95, and/or synaptophysin gene expression. In some aspects, the miRNA inhibitor can be used to treat a disease or condition associated with an increased level of caspase-3 protein or gene expression. The miRNA inhibitor useful for the present disclosure can inhibit miR-485 expression and/or activity, which in turn can increase the level of SIRT1, PGC-1?, CD36, LRRK2, NRG1, STMN2, VLDLR, NRXN1, GRIA4, NXPH1, PSD-95, and/or synaptophysin protein or gene expression; and/or can decrease the level of caspase 3 protein or gene expression.

Abstract: The present disclosure relates to the use of PGC-1? expression to identify a subject that is conducive to treatment with a ma-485 inhibitor. In some aspects, the subject suffers from a disease or disorder associated with reduced PGC-1? expression. In some aspects, the PGC-1? expression is measured in the serum of the subject.

Abstract: The present disclosure relates to the use of SIRT1 expression to identify a subject that is conducive to treatment with a miR-485 inhibitor. In some aspects, the subject suffers from a disease or disorder associated with reduced SIRT1 expression. In some aspects, the SIRT1 expression is measured in the serum of the subject.

Abstract: The present disclosure includes the use of a miRNA inhibitor for treating a tauopathy associated with a decreased level of SIRT1 protein or SIRT1 gene expression, PGC-1? protein and/or PGC-? gene expression, and/or CD36 and/or CD36 gene expression.

Abstract: The present invention relates to a compound represented by Formula 1 wherein A, B, L, X, and R1 to R6 are as described herein, or a pharmaceutically acceptable salt thereof, which serves as a GLP-1 receptor agonist and may be useful in the prevention or treatment of a disease associated with GLP-1 activity.

Abstract: The present invention relates to a meal service management system and an operating method therefor, the system being capable of providing information on food ingested by a user to whom a meal service is to be provided and customized information related thereto, and managing food leftover in a meal service. According to an embodiment of the present invention, a scanner device is used such that a user to whom a meal service is to be provided and a food tray before and after meals are identified, and thus a meal service amount and a leftovers food amount are acquired, and leftovers food information of each user and useful information associated therewith are provided on the basis of the same, and thus users can easily determine their eating habits, nutritional status and the like and the users can be induced to attempt reducing leftovers food by themselves.

Abstract: Provided are a food-information inputting method and apparatus. The food-information inputting method may include operating in a photographing mode where an input guide and an input button moved along the input guide are displayed on a photographing screen; and receiving at least one piece of food information using the input guide and the input button, while operating in the photographing mode.

Abstract: The present invention relates to a meal service management system and an operating method therefor, the system being capable of providing information on food ingested by a user to whom a meal service is to be provided and customized information related thereto, and managing food leftover in a meal service. According to an embodiment of the present invention, a scanner device is used such that a user to whom a meal service is to be provided and a food tray before and after meals are identified, and thus a meal service amount and a leftovers food amount are acquired, and leftovers food information of each user and useful information associated therewith are provided on the basis of the same, and thus users can easily determine their eating habits, nutritional status and the like and the users can be induced to attempt reducing leftovers food by themselves.

Abstract: The present disclosure includes cationic carrier units comprising (i) a water soluble polymer, (ii) a positively charged carrier, and (iii) an adjuvant moiety, wherein when the cationic carrier unit is mixed with an anionic payload (e.g., an antisense oligonucleotide) that electrostatically interacts with the cationic carrier unit, the resulting composition self-organizes into a micelle encapsulating the anionic payload in its core. The cationic carrier units can also comprise a tissue specific targeting moiety, which would be displayed on the surface of the micelle. The disclosure also includes micelles comprising the cationic carrier units of the disclosure, methods of manufacture of cationic carrier units and micelles, pharmaceutical compositions comprising the micelles, and also methods of treating diseases or conditions comprising administering the micelles to a subject in need thereof.

Abstract: A method for measuring food is provided. The method calculates an amount of food based on information on a size of a plurality of spaces, a depth of the plurality of spaces, and a capacity of the plurality of spaces formed in a tableware containing the food and an image photographed by photographing.

Abstract: Provided are an apparatus and a method for controlling an interrupt rate for a processor based on processor utilization. Accordingly, it is possible to improve an I/O response latency and improve energy efficiency.